(Reuters) – Pfizer Inc and German partner BioNTech SE are expected to ask the U.S. Food and Drug Administration in the next few days to authorize their COVID-19 vaccine booster shot for 16 and 17-year olds, the Washington Post reported on Monday, citing two people familiar with the matter.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Krishna Chandra Eluri)
